
Drovix delivers highest-grade execution for hedge funds and quant desks — zero market impact, discreet block execution, high fill rates and co-location hosting for latency-sensitive strategies, all under a single principal counterparty.
Funds and quant desks come to Drovix for execution that protects alpha. Large orders are internalised or worked discreetly against aggregated liquidity to minimise market impact and information leakage, with co-location and sub-millisecond infrastructure for latency-sensitive flow. All counterparties are subject to onboarding, KYB, suitability, credit and jurisdictional review.
Large orders are handled through Drovix internalisation and bespoke liquidity pools to minimise information leakage and market impact — designed to keep your footprint off the public tape.
Size is worked discreetly as principal against aggregated liquidity, protecting strategy confidentiality and reducing adverse selection on institutional clip sizes.
Our smart order router targets the deepest available liquidity per ticket and is engineered to minimise last-look rejections — so more of your alpha lands in the trade.
Co-location and proximity hosting at Equinix NY3, LD4, SG1 and TY3 for latency-sensitive and HFT strategies, with redundant cross-connect connectivity.
A C++/Aeron core targets <1ms internal execution. Client round-trip latency remains network-dependent by location and venue, with deterministic performance as the design goal.
Native FIX 4.4, REST and WebSocket connectivity for direct integration with your EMS/OMS, signal engines and proprietary execution stack.
Operational parameters describe the Drovix execution framework. They are not guarantees of pricing, fill rates, latency or trading outcomes.
How execution works
When a fund trades with Drovix, Drovix takes the other side as principal and works the resulting exposure through internalisation and bespoke liquidity pools — rather than exposing your size on a public venue. Smart order routing internalises or routes to third-party liquidity providers to maintain best execution under prevailing market conditions.
Order arrives over a direct API or co-located session on an approved instrument and size.
Automated pre-trade controls check limits, collateral and quote validity in real time.
Drovix prices as principal and internalises to minimise market impact and leakage.
Any residual is routed discreetly to third-party liquidity for best execution.
Fills are reconciled; slippage attribution and TCA delivered on agreed schedules.
What funds receive
Every Drovix fund relationship is supported by execution, hosting and reporting designed for performance-sensitive, compliance-aware institutional trading.
Internalisation and discreet handling designed to keep large orders off the public tape.
Proximity hosting at Equinix NY3, LD4, SG1 and TY3 for latency-sensitive and HFT strategies.
Fill-level transaction cost analysis with slippage attribution for your own best-execution review.
Eligible funds and quant desks can begin the counterparty review process via the portal, or speak with the execution desk first.
Risk notice. Engaging in leveraged products such as Forex and CFDs involves a high level of risk. The Drovix offering is directed at Eligible Counterparties and Professional Clients and is not intended for retail clients. Leverage can amplify both profits and losses; a counterparty may lose more than its initial margin. Ensure that the firm understands how these products work and can bear the risk of capital loss.
Scope. Drovix is not a public exchange, multilateral trading facility (MTF), organised trading facility (OTF) or ECN. Internalisation and discreet execution occur bilaterally between Drovix, acting as principal, and approved institutional counterparties — not on a multilateral venue. Drovix may route flow to third-party liquidity providers to maintain best execution under prevailing market conditions.
No retail. Drovix does not provide execution or any related services to retail clients. Services are offered only to approved professional clients, eligible counterparties and institutional clients, and not in jurisdictions where Drovix is not authorised or permitted to provide them.